Pulsating airflow and drug delivery to paranasal sinuses

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 19, Issue 1, 2011, Pages 48-53

  Möller, Winfried ^a   Lübbers, Christian ^b   Münzing, Wolfgang ^c   Canis, Martin ^d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Department of Otolaryngology Head and Neck Surgery   (Germany)

^c Department of Nuclear Medicine ^*  (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

chronic rhinosinusitis; clearance; krypton gas scintigraphy; paranasal sinus ventilation; pulsating aerosol; topical therapy

Indexed keywords

STEROID;

AEROSOL; ANTIBIOTIC THERAPY; ARTICLE; DRUG DELIVERY SYSTEM; ENDOSCOPIC SINUS SURGERY; FUNCTIONAL ENDONASAL SINUS SURGERY; HUMAN; NOSE AIRFLOW; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANASAL SINUS; PRIORITY JOURNAL; PULSATILE FLOW; RHINOSINUSITIS; SCINTILLATION CAMERA; SYSTEMIC THERAPY; TOPICAL TREATMENT; VOLUNTEER;

ADMINISTRATION, INTRANASAL; AEROSOLS; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; HUMANS; RHINITIS; SINUSITIS;

EID: 78751613860     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283420f39     Document Type: Article

References (32)

1. Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol 2010; 125:S103-S115.
2. Fokkens W, Lund V, Mollol J. The European Position Paper on Rhinosinusitis and Nasal Polyps (EP3OS) group. Rhinology 2007; 45:1-137.
3. Gosepath J, Mann WJ. Current concepts in therapy of chronic rhinosinusitis and nasal polyposis. ORL J Otorhinolaryngol Relat Spec 2005; 67:125-136.
4. Hyo N, Takano H, Hyo Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. Rhinology 1989; 27:17-26.
5. Suman JD. Nasal drug delivery. Expert Opin Biol Ther 2003; 3:519-523.
6. Maniscalco M, Sofia M, Weitzberg E, Lundberg JO. Sounding airflow enhances aerosol delivery into the paranasal sinuses. Eur J Clin Invest 2006; 36:509-513.
7. Kauf H. Penetration ability of aerosols into secondary spaces. Eur Arch Otorhinolaryngol 1968; 190:95-108.
8. Hwang PH, Woo RJ, Fong KJ. Intranasal deposition of nebulized saline: a radionuclide distribution study. Am J Rhinol 2006; 20:255-261.
9. Möller W, Schuschnig U, Khadem Saba G, et al. Pulsating aerosols for drug delivery to the sinuses in healthy volunteers. Otolaryngol Head Neck Surg 2010; 142:382-388.
10. Djupesland PG, Skretting A, Winderen M, Holand T. Breath actuated device improves delivery to target sites beyond the nasal valve. The Laryngoscope 2006; 116:466-472.
11. Harvey RJ, Debnath N, Srubiski A, et al. Fluid residuals and drug exposure in nasal irrigation. Otolaryngol Head Neck Surg 2009; 141:757-761.
12. Snidvongs K, Chaowanapanja P, Aeumjaturapat S, et al. Does nasal irrigation enter paranasal sinuses in chronic rhinosinusitis? Am J Rhinol 2008; 22:483-486.
13. Helmholtz Hv. On the sensations of tone as a physiological basis for the theory of music (in German). Braunschweig, Germany: F. Vieweg; 1863.
14. Guillerm R, Badre R, Flottes L, et al. A new method of aerosol penetration into the sinuses (in French). Presse Med 1959; 67:1097-1098.
15. Sato Y, Hyo N, Sato M, et al. Intra-nasal distribution of aerosols with or without vibration. Z Erkr Atmungsorgane 1981; 157:276-280.
16. ICRP Publication 66. Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. Ann ICRP 1994; 24:1-482.
17. Knoch M, Keller M. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems. Expert Opin Drug Deliv 2005; 2:377-390.
18. Schuschnig U, Keller M, Klopfer E, et al. Drug delivery to the nasal and paranasal cavities: critical cast dimensions and aerosol dynamics. In: Dalby RN, Byron PR, Peart J, et al., editors. Respiratory drug delivery 2008 Arizona. Scottsdale, AZ, USA: Virginia Commonwealth University; 2008 . pp. 227- 238.
19. Wagner HN Jr. Regional ventilation and perfusion. In: Wagner HN, Szabo Z, Buchanan J, editors. Principles of nuclear medicine. Philadelphia: Saunders; 1995. pp. 887-895.
20. Möller W, Schuschnig U, Meyer G, et al. Ventilation and aerosolized drug delivery to the paranasal sinuses using pulsating airflow: a preliminary study. Rhinology 2009; 47:405-412.
21. Möller W, Schuschnig U, Meyer G, et al. Ventilation and drug delivery to the paranasal sinuses: studies in a nasal cast using pulsating airflow. Rhinology 2008; 46:213-220.
22. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004; 114:923-930.
23. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005; 116:1289-1295.
24. Fiocchi A, Sarratud T, Bouygue GR, et al. Topical treatment of rhinosinusitis. Pediatr Allergy Immunol 2007; 18:62-67.
25. Novembre E, Mori F, Pucci N, et al. Systemic treatment of rhinosinusitis in children. Pediatr Allergy Immunol 2007; 18:56-61.
26. Joe SA, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008; 139:340-347.
27. Kalish LH, Arendts G, Sacks R, Craig JC. Topical steroids in chronic rhinosinusitis without polyps: A systematic review and meta-analysis. Otolaryngol Head Neck Surg 2009; 141:674-683.
28. Molimard M. How to achieve good compliance and adherence with inhalation therapy. Curr Med Res Opin 2005; 21:S33-S37.
29. Saijo R, Majima Y, Hyo N, Takano H. Particle deposition of therapeutic aerosols in the nose and paranasal sinuses after transnasal sinus surgery: a cast model study. Am J Rhinol 2004; 18:1-7.
30. Mainz J, Mentzel HJ, Schneider G, et al. Sinu-nasal inhalation of Dornase alfa in CF. Results of a double-blind placebo-controlled pilot trial. J Cyst Fibros 2008; 7:S27.
31. Mainz JG, Koitschev A. Management of chronic rhinosinusitis in CF. J Cyst Fibros 2009; 8:S10-S14.
32. Pynnonen MA, Kim HM, Terrell JE. Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients. Am J Rhinol Allergy 2009; 23:40-45.